MedPath

In-Use Test With a Cosmetic Product

Not Applicable
Completed
Conditions
Dermatitis, Atopic
Registration Number
NCT03252730
Lead Sponsor
Dr. August Wolff GmbH & Co. KG Arzneimittel
Brief Summary

The aim of the study is to evaluate the tolerance of the product WO 4260 by a dermatologist. Additional objectives of this clinical in-use study are to evaluate the cosmetic features and acceptance of the product by means of a questionnaire in an interview situation and by skin hydration measurements on the scalp.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • age: ≥ 18 years
  • sex: approx. 50% male and approx. 50% female
  • users of hair tonic for dry scalp
  • dry, itchy scalp prone to atopic eczema / atopic dermatitis
Exclusion Criteria
  • any deviation from the above-mentioned criteria
  • users of sour hair rinse
  • subjects who wash their hair more than once a day
  • other dermatological disorders (scars, moles) on the scalp
  • known incompatibilities to cosmetics and ingredients of cosmetic test products (please see INCI)
  • topical medication in the test area within 1 month prior to study start
  • systemic medication with anti-inflammatory agents and antibiotics within 2 weeks prior to starting of the study
  • systemic medication with retinoids, antihistamines and/or immunomodulators (e.g. cortisone, corticosterone, chemotherapeutic agents) within 4 weeks prior to starting of the study
  • systemic illness of the subject at the beginning of the study
  • pregnancy and period of breastfeeding

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Tolerance of the Test Product on the Scalpafter 4 weeks of treatment

Change from Baseline Tolerance on the Scalp at 4 weeks

Secondary Outcome Measures
NameTimeMethod
Skin Hydration of the Scalpbefore product treatment; after 2 and 4 weeks of treatment

The measurement is performed using the DermaLab® device with the moisture pin (Cortex Technology)

Performance of the Test Productafter 4 weeks of treatment

Subjective assessment of product performance in a questionnaire-based interview

Tolerance of the Test Product on the Scalpafter 2 weeks of treatment

Dermatological assessment of the Scalp concerning the Tolerance of the Test Product regarding erythema, edema dryness etc. Each item is scored 0=absent to 4=extreme.

Trial Locations

Locations (1)

SIT Skin Investigation and Technology Hamburg GmbH

🇩🇪

Hamburg, Germany

SIT Skin Investigation and Technology Hamburg GmbH
🇩🇪Hamburg, Germany

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.